Thursday, October 14, 2021 2:57:04 PM
Over the last couple of months I have accumulated a position in the CEHD shell. Bought shares in the .06-.095 range, with a current cost basis under 7.7 cents. I have been somewhat surprised that shares have continued to be available under the 10-cent level, after what appears to be change in control of the shell. Overall, the risk/reward looks pretty interesting to me at this level/valuation. Legacy shares are about 16.8M (more than 6% of the current total of 266.8M outstanding). Structurally this Barbara Bauman shell looks reasonably good, and the valuation of the legacy share position at my cost basis is less than $1.3M, so I think there is decent upside potential.
With the recent change in officer/directors, it appears to me that Barbara has likely sold control of the shell. Both Rami Bakir and Khalil Ouar are associated with MessaBen (a water treatment/reuse company). I'm not sure if the plan is to bring MessaBen public, or if they have other directions they want to take the shell.
https://www.linkedin.com/in/rami-bakir-b8588911/
https://www.linkedin.com/in/khalil-ouar-00729619/
https://messaben.com/
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM